Fig. 6From: Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitorsKaplan–Meier survival curves for the association of dermatologic toxicity (a), thyroid toxicity (b), pneumonitis (c), and cardiotoxicity (d) with OSBack to article page